This year’s Sareum Plc (SAR) AGM was held at the offices of Citigate Dewe Rogerson, 3 London Wall Buildings, London Wall, London EC2M 5S, on Tuesday December 18th commencing at 10:00 For investors who are unfamiliar with the company, SAR is a small biopharmaceutical company specialising in identifying and developing small molecule kinase inhibitors which would ideally be suitable for both iv. and oral administration. Target indications include various cancer types and auto immune diseases such as lupus, RA and psoriasis. SAR currently has four compounds at various stages of development. SAR was founded in 2003 by a group of senior managers from the US biotech Millennium Pharmaceuticals, this followed the closure of Millennium’s operations in the UK in order to concentrate their business in the United States (note Millennium
...Not a member? Join today
Joining ShareSoc helps to empower our collective voice in representing investors, but we also offer exclusive benefits:
Member events & Masterclasses
Regular newsletter
Member only on-line Forums / Q&As
Company data and Voting Guidance
Educational resources
Get involved in our activities
Already a member?
Log in to your account to access this content and all of your other ShareSoc membership benefits.